Analysis of datasets indicated that the expression level of TMPRSS2 was considerably reduced in many tumour tissues, relative to their normal counterparts, and the level of TMPRSS2 expression was considerably associated with the prognosis of the brain, blood, colorectal, breast, ovarian, lung and soft tissue cancer. This evidence concerns the gene TMPRSS2 and neoplasm.